Fri Aug 29 13:14:50 SGT 2014  
SINGAPORE
HAIR™
    Hair loss, Singapore (SG)

Hair loss, Singapore (SG)

Summary

Hair loss, Singapore (SG) @singaporehair_com: Hair loss treatment clinic, Singapore

Description

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hair loss, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

Baldness cure comes at a price
Mon, 25 Aug 2014 05:45:19 +0100 | Telegraph Health
A breakthrough in tackling alopecia has been announced, but the drugs are costly, says James LeFanu (Source: Telegraph Health)

Histopathological investigation of clinically non‐affected perilesional scalp in alopecias detected unexpected spread of disease activities
Mon, 25 Aug 2014 00:00:00 +0100 | The Journal of Dermatology
Abstract

HASOL ANTI HAIR LOSS DAY TONIC (Salicylic Acid, Niacinamide) Spray [Ecomine Co., Ltd.]
Fri, 22 Aug 2014 05:00:00 +0100 | DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)
Updated Date: Aug 22, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis
Fri, 22 Aug 2014 00:00:00 +0100 | Clinical And Experimental Dermatology
ConclusionsHistomorphometric results establish CTE as a distinct disorder, separate from FPHL from its outset. Its pathogenic mechanisms are also distinct. These findings support the proposed mechanism of ‘immediate telogen release’ for CTE, leading to cycle synchronization. For FPHL, accelerated anagen follicular mitotic rates and, thus, higher Ki‐67 and VEGF values, would leave less time for differentiation, resulting in hair miniaturization. (Source: Clinical And Experimental Dermatology)

PET scan image of chronic panniculitis mimicking extranodal lymphoma
Fri, 22 Aug 2014 00:00:00 +0100 | Arthritis and Rheumatism
Abstract

Bone Marrow Drug Reverses Alopecia, Restores Hair Growth
Thu, 21 Aug 2014 16:09:09 +0100 | Pharmaceutical Online News
Researchers from Columbia University Medical Centre reported that the bone marrow drug ruxolitinib, marketed as Jakavi by Novartis, completely reversed baldness in three patients with alopecia. (Source: Pharmaceutical Online News)

Budesonide for maintenance of remission in Crohn's disease.
Thu, 21 Aug 2014 00:00:00 +0100 | Cochrane Database of Systematic Reviews
CONCLUSIONS: These data suggest budesonide is not effective for maintenance of remission in CD, particularly when used beyond three months following induction of remission. Budesonide does have minor benefits in terms of lower CDAI scores and longer time to relapse of disease. However, these benefits are offset by higher treatment-related adverse event rates and more frequent adrenocorticoid suppression in patients receiving budesonide.

Drug Restores Hair in Alopecia Patients: FAQ
Wed, 20 Aug 2014 07:00:00 +0100 | MedicineNet Skin General
Title: Drug Restores Hair in Alopecia Patients: FAQCategory: Health NewsCreated: 8/20/2014 11:00:00 AMLast Editorial Review: 8/20/2014 12:00:00 AM (Source: MedicineNet Skin General)

Genetics Home Reference: T-cell immunodeficiency, congenital alopecia, and nail dystrophy
Tue, 19 Aug 2014 14:48:17 +0100 | NLM General Announcements
http://ghr.nlm.nih.gov/condition/t-cell-immunodeficiency-congenital-alopecia-and-nail-dystrophy (Source: NLM General Announcements)

How a promising new drug may help combat baldness caused by alopecia
Mon, 18 Aug 2014 23:15:00 +0100 | Los Angeles Times - Science
A cure for patchy baldness may be on the way, according to a new study published Sunday in the journal Nature Medicine. (Source: Los Angeles Times - Science)